Drug Shortage Report for PROPYLTHIOURACIL TABLETS
Report ID | 213216 |
Drug Identification Number | 02523019 |
Brand name | PROPYLTHIOURACIL TABLETS |
Common or Proper name | PROPYLTHIOURACIL TABLETS |
Company Name | PHEBRA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | PROPYLTHIOURACIL |
Strength(s) | 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | Bottle of 100 tablets |
ATC code | H03BA |
ATC description | ANTITHYROID PREPARATIONS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2023-12-13 |
Actual start date | 2023-12-13 |
Estimated end date | 2024-02-07 |
Actual end date | 2024-02-01 |
Shortage status | Resolved |
Updated date | 2024-02-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7171 FREDERICK-BANTING MONTREAL, QUEBEC CANADA H4S 1Z9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2024-02-02 | English | Compare |
v5 | 2024-02-01 | French | Compare |
v4 | 2024-02-01 | English | Compare |
v3 | 2023-12-14 | English | Compare |
v2 | 2023-12-13 | French | Compare |
v1 | 2023-12-13 | English | Compare |
Showing 1 to 6 of 6